Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.455 USD | -1.30% | +3.92% | +14.77% |
Business Summary
Number of employees: 145
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Targeted Protein Degradation
100.0
%
| 31 | 100.0 % | 21 | 100.0 % | -33.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 31 | 100.0 % | 21 | 100.0 % | -33.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 20-09-13 |
Kendra Adams
DFI | Director of Finance/CFO | 48 | 20-11-19 |
Chief Tech/Sci/R&D Officer | - | 20-12-31 | |
Stewart Fisher
CTO | Chief Tech/Sci/R&D Officer | 57 | 16-04-30 |
Leonard Reyno
CTO | Chief Tech/Sci/R&D Officer | 61 | 23-07-09 |
Courtney Solberg
IRC | Investor Relations Contact | - | - |
Mark Mossler
AUD | Comptroller/Controller/Auditor | 51 | 23-05-31 |
Scott Boyle
PRN | Corporate Officer/Principal | 46 | 21-12-31 |
Adrian Bignami
PRN | Corporate Officer/Principal | - | 21-03-31 |
Jolie Siegel
LAW | General Counsel | 47 | 20-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 15-11-30 |
Glenn Dubin
BRD | Director/Board Member | 67 | 21-03-11 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 15-11-30 |
Donna Grogan
BRD | Director/Board Member | 67 | 22-07-28 |
Owen Hughes
BRD | Director/Board Member | 49 | 11-19 |
Kenneth Anderson
FOU | Founder | 72 | 15-09-30 |
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 20-09-13 |
Malcolm Salter
BRD | Director/Board Member | 84 | 15-11-30 |
Utpal Koppikar
BRD | Director/Board Member | 53 | 22-03-15 |
Laura Bessen
BRD | Director/Board Member | 61 | 22-07-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,600,669 | 60,834,824 ( 88.68 %) | 0 | 88.68 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.77% | 450M | |
+20.36% | 42.68B | |
-2.23% | 42.4B | |
+45.09% | 40.04B | |
-6.20% | 28.31B | |
+5.13% | 24.94B | |
-20.30% | 18.96B | |
+30.66% | 12.3B | |
-3.22% | 11.95B | |
-4.07% | 11.55B |
- Stock Market
- Equities
- CCCC Stock
- Company C4 Therapeutics, Inc.